December 2015 - January 2016 Newsletter
Deadline Extended to Jan. 18, 2016 - IASLC Fellowship/Young Investigator Awards
Applications are now welcome for the 2016-2017 Fellowship and Young Investigator Awards. There will be a minimum of three one-year awards of $40,000, with at least one recipient from each region (North America, Europe and the rest of the world). The funding period will be July 1, 2016–June 30, 2017. The goal is to reward scientific excellence and to encourage innovative research in lung cancer prevention and translational medicine. Applications will be evaluated by a Scientific Review Panel for their merit, innovation and potential impact on the management of lung cancer.
The deadline to submit is now extended to Jan. 18, 2016. Click here for more information.
4th AACR-IASLC International Joint Conference on Lung Cancer Translational Science: From the Bench to the Clinic
Best of WCLC 2015
Asia Pacific Lung Cancer Conference 2016
DEADLINE EXTENDED: The IASLC APLCC Research Fellowship Award is a one-year $40,000 award for an applicant from Southeast Asia. The APLCC grant allows an applicant to work in in the U.S. or EU to obtain laboratory skills and develop collaborations. The new deadline to submit is Jan. 4, 2016. Announcement | Details
Latin American Lung Cancer Conference 2016
IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology
Elsevier Takes Over as JTO Publisher
The January 2016 issue of the Journal of Thoracic Oncology is the first published by our new publisher, Elsevier.
Along with the new look of the journal, there are many new features available to our authors and readers:
We want the JTO to be where readers turn for the most up to date and authoritative information on thoracic malignancies.
The IASLC Foundation is wrapping up its year-end fundraising drive. We are requesting all members to consider donating to this wonderful cause. All proceeds support the education of the fellows and young investigators who will be the next generation of lung cancer physicians and scientists. We especially would like to thank BioBridges Strategies for their generous donation "in honor of Denise Aberle, MD, for her tireless contribution to lung cancer research." We want to thank all those who donated to the IASLC Foundation in the past year, specifically the following members for their donations:
Please visit www.iaslc.org/foundation to donate.
Lung Cancer Survivor Takes Super Bowl Challenge for IASLC Foundation
Lung cancer survivor Kathy Weber is taking part in Team Draft’s 2016 Lung Cancer Survivors Super Bowl Challenge, raising money on behalf of the IASLC Foundation to help further cancer research and create new ways to treat the disease.
Team Draft is an initiative of the Chris Draft Family Foundation created by former NFL linebacker Chris Draft and his late wife during her year-long struggle with Stage IV lung cancer. The Super Bowl Challenge recruits lung cancer survivors to raise funds to find new ways to combat the disease. The winners (the top three teams) enjoy trips to the Super Bowl, the NFL Pro-Bowl and the Taste of the NFL. Kathy is one of several lung cancer survivors from dozens of locations in the U.S. working to raise money as part of the Super Bowl Challenge.
Membership Feedback Requested
Chance to win an iPad when you complete the IASLC 2015 Membership Survey
Responding to the survey enters you into a random drawing to win an Apple iPad.
Please note the survey link was emailed individually to all members, and will be anonymous, unless you provide your contact details during the survey. If you did not receive the survey in your email inbox, please contact
The anonymous survey will take members no longer than 5 minutes to complete.
Thank you for your feedback!
International Funding Opportunities
As a service to our members we post funding opportunities related to lung cancer and other thoracic malignancies on our website when we receive information from grantors.
We currently have four opportunities posted:
These opportunities are available to applicants from all countries. Click here to learn more.
The National Cancer Institute (NCI) is also offering a public pre-application consultation webinar on Jan. 22, 2016 at 2 p.m. EST. Click here for more information.
Former JTO Editor Retires
The IASLC congratulates James Jett, MD, on his retirement from National Jewish Health in Denver, Colo. Dr. Jett joined National Jewish Health in 2010 to assist in the development of the oncology program and conduct clinical research trials related to screening and the early detection of lung cancer. Dr. Jett was also the first Editor-in-Chief of The Journal of Thoracic Oncology. He held that role from 2006 to 2012, building up the journal to a highly-recognized and well-established scientific periodical and resource. Dr. Jett is moving to California to be closer to his family, but he will still continue his work to help those with lung cancer. Oncimmune, Inc. (biomarkers of cancer) recently appointed Dr. Jett as its Chief Medical Officer.
Johnson Elected President of ASCO
Long-time IASLC member Bruce E. Johnson, MD, FASCO, was recently elected President of the American Society of Clinical Oncology (ASCO). His term begins in June 2017 and he will take office as president-elect during the ASCO Annual Meeting in Chicago in June 2016. Dr. Johnson has been a member of IASLC for more than 20 years.
ASCO’s network comprises nearly 40,000 oncology professionals, about one-third of them in 120 countries outside the U.S.
Bunn to Receive Major ASCO Award
ASCO announced that it will award Paul A. Bunn, Jr., former IASLC CEO, with its prestigious David A. Karnofsky Memorial Award and Lecture for 2016 at the next ASCO Annual Meeting on June 4, 2016. First presented in 1970, the David A. Karnofsky Memorial Award and Lecture honors Dr. Karnofsky by recognizing an oncologist who has made outstanding contributions to cancer research, diagnosis and/or treatment. The award consists of an honorarium, a commemorative plaque, and support to the recipient to attend the ASCO Annual Meeting. Dr. Bunn will also deliver a 30-minute lecture at the ASCO Annual Meeting.
Join us in congratulating Dr. Bunn on this well-deserved honor.
Invitation to Host APLCC 2018
The IASLC APLCC (Asian Pacific Lung Cancer Conference) meeting is soliciting bids for the APLCC IASLC conference in 2018. Attendance is expected to range from 800 to 1,000.
The conference must be located in the Asian-Pacific region and it will last three to four days.
Applications will be accepted after Dec. 1, 2015, and not later than Feb. 1, 2016. The applications will be reviewed by the IASLC Executive Committee/Board of Directors at the Board meeting in February 2016. Finalists will be notified in March 2016.
Please apply by email to Pia.Hirsch@iaslc.org no later than Feb. 1, 2016.
January 2016: The International Association for the Study of Lung Cancer (IASLC) and the Journal of Thoracic Oncology (JTO) are pleased to present this feature each month to highlight certain articles of interest. The selected articles each month will be made available to the public for a limited time at the time of print. The articles below from the January issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification For Lung Cancer
The IASLC Lung Cancer Staging Committee has embarked on revisions for the 8th edition of the TNM classification for lung cancer. The first three manuscripts describing the T, N and M descriptors were published in July, November and December 2015. In this issue, Goldstraw and colleagues provide information on proposals for the revision of the TNM groupings.
The IASLC Advanced Radiation Therapy (ART) Committee has provided a number of topical reviews for JTO over the past year. This tradition continues in this issue of the journal. Palma and colleagues review the radiotherapeutic management of non-small cell lung cancer in low to middle income countries in an excellent paper.
Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer
The final featured article by Liu and coworkers is a report on germ line mutations in familial and sporadic lung cancer, derived from exome sequencing.
Welcome New Members - Invite Colleagues!
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
Welcome New IASLC Members through December 22, 2015 (listed by country, then name):
IASLC Members Participate in Lung Cancer Awareness Month
Dr. Irina Veytsman (pictured right) participated in PinnacleHealth's LCAM events in Pennsylvania. PinnacleHealth took part in a community awareness walk where Dr. Veystman distributed lung cancer awareness and screening materials. There was also a community seminar on EPA data that indicates higher than expected prevalence of lung cancer in a specific area in Pennsylvania and Dr. Veytsman was part of a lung cancer screening awareness video that received nearly 20,000 views after it was shared on social media.
Dr. Anne Tsao participated in a LCAM radio media tour on behalf of MD Anderson Cancer Center in Houston, Texas. She reached approximately 3 million listeners during a conversation with 24/7 News Source, a national news network. She discussed the latest prevention and screening developments for lung cancer as well as the most exciting treatment advancements. She also shed light on national lung cancer rates and the most common risk factors. Dr. Tsao also spoke with American Urban Radio Networks, reaching approximately 1.5 million listeners, extensively discussing lung cancer prevention and guidelines. She also went into detail regarding tumor profiling and immunotherapy for lung cancer. Other interviews included outlets reaching audiences in Arizona, Georgia, Illinois, Indiana, Michigan, North Carolina, Tennessee, and Washington. The estimated total audience reach is approximately 5.7 million.
Dr. Grace Dy, Dr. Alex A. Adjei and many more participated in the Roswell Park Cancer Institute's Breath of Life Lung Cancer Event in Buffalo, New York. Around 150 people, including patients, family members, caregivers and RPCI staff attend the annual event, which began in 2008. The event is not meant to raise funds, but rather educate the lay community in order to increase awareness of prevention and treatment approaches for lung cancer.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
February 20 - 23 2019Santa Monica, California
April 3 - 5 2019New York, New York
April 10 - 13 2019Geneva, Switzerland